Condition: Prostate Cancer · Prostate Adenocarcinoma · Sponsor: Profound Medical Inc.
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
Men with localized, intermediate risk prostate cancer will be randomized to undergo either radical prostatectomy or the TULSA procedure, with a follow-up of 10 years in this multi-centered randomized control trial. This study will determine whether the TULSA procedure is as effective and more safe compared to radical prostatectomy.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Arizona State Urological Institute | Chandler, Arizona, United States | — |
| East Valley Urological Center | Mesa, Arizona, United States | — |
| Investigate MD | Scottsdale, Arizona, United States | — |
| Atlantic Urology Medical Group | Long Beach, California, United States | — |
| Urology Group of Southern California | Los Angeles, California, United States | — |
| University of California, Los Angeles | Los Angeles, California, United States | — |
| Comprehensive Urology Medical Group | Los Angeles, California, United States | — |
| Alarcon Urology Center | Montebello, California, United States | — |
| Pasadena Urological Medical Group | Pasadena, California, United States | — |
| Stanford Cancer Center | Stanford, California, United States | — |
| Yale Cancer Center | New Haven, Connecticut, United States | — |
| Mayo Clinic Jacksonville | Jacksonville, Florida, United States | — |
+ 10 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.